Cargando…
Quantitative proteomics analysis in small cell carcinoma of cervix reveals novel therapeutic targets
BACKGROUND: As a rare pathologic subtype, small cell carcinoma of the cervix (SCCC) is characterized by extensive aggressiveness and resistance to current therapies. To date, our knowledge of SCCC origin and progression is limited and sometimes even controversial. Herein, we explored the whole-prote...
Autores principales: | Qiu, Haifeng, Su, Ning, Wang, Jing, Yan, Shuping, Li, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10082492/ https://www.ncbi.nlm.nih.gov/pubmed/37031178 http://dx.doi.org/10.1186/s12014-023-09408-x |
Ejemplares similares
-
Real-world Efficacy Data on Anti-Angiogenic Drugs in Recurrent Small
Cell Cervical Carcinoma: A Retrospective Study
por: Qiu, Haifeng, et al.
Publicado: (2023) -
Small Cell Carcinomas of the Uterine Cervix and Lung: Proteomics Reveals Similar Protein Expression Profiles
por: Egawa-Takata, Tomomi, et al.
Publicado: (2018) -
Quantitative proteomics reveals novel therapeutic and diagnostic markers in hypertension
por: Matafora, Vittoria, et al.
Publicado: (2014) -
Quantitative proteomics identification of phosphoglycerate mutase 1 as a novel therapeutic target in hepatocellular carcinoma
por: Ren, Fenglian, et al.
Publicado: (2010) -
Data-independent acquisition-based quantitative proteomic analysis of m.3243A>G MELAS reveals novel potential pathogenesis and therapeutic targets
por: Chang, Xueli, et al.
Publicado: (2022)